CATALYST PHARMACEUTICALS, INC.: net_income
| Value | {"amount": 39482000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | CATALYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ca04b57c-d9a8-4d50-a90e-bf9090fdc5a3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-077228Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001369568/net-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ca04b57c-d9a8-4d50-a90e-bf9090fdc5a3
History
- no predecessors — first report